Home › OneOme, Genome.One Partner to Offer Genetic Risk, PGx Service in Australia

OneOme, Genome.One Partner to Offer Genetic Risk, PGx Service in Australia

Jul 05, 2017

NEW YORK (GenomeWeb) – Australian firm Genome.One and US-based OneOme said today that they have partnered to provide a joint service in Australia to analyze individuals' genetic disease risks and pharmacogenomic-related variants.

As part of the service launched earlier this month, customers will receive genome sequencing provided by Genome.One and pharmacogenomic testing using OneOme's RightMed test.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Nov
05
Featured Webinar

Overcoming Challenges in Solid Tumor Testing with Advanced AI

Sponsored by
Sophia Genetics

With the Next Generation Sequencing (NGS), genomes sequencing has been democratized over the last decades with the detection of genomic alterations, thus replacing Sanger sequencing.

What's Popular?

In Molecular Diagnostics

  1. Roche Patent Invalidation Affirmed in TB Testing Lawsuit Against Cepheid

  2. Liquid Biopsy IDs More NSCLC Mutations, Yields Patient Therapy Response in Study of Guardant Test

  3. FDA Approves Myriad Genetics BRCA CDx With Pfizer's Metastatic Breast Cancer Drug

  4. Sanofi Genzyme, PerkinElmer Launch Free Dx Program for Patients With Lysosomal Storage Disorders

  5. BD Obtains CE Mark for Molecular TB, MDR-TB Assay

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.